These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 16432874)
1. Effects of sarpogrelate hydrochloride in a patient with chronic graft-versus-host disease: a case report. Hayashi T; Morishita E; Ontachi Y; Yamazaki M; Asakura H; Yoshida T; Nakao S Am J Hematol; 2006 Feb; 81(2):121-3. PubMed ID: 16432874 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of imatinib mesylate in the treatment of refractory sclerodermatous chronic GVHD. Magro L; Catteau B; Coiteux V; Bruno B; Jouet JP; Yakoub-Agha I Bone Marrow Transplant; 2008 Dec; 42(11):757-60. PubMed ID: 18762765 [TBL] [Abstract][Full Text] [Related]
4. Thrombopoietin concentrations in peripheral blood correlated with platelet numbers in two patients with thrombocytopenia by chronic graft-versus-host disease. Hirayama Y; Sakamaki S; Tsuji Y; Sagawa T; Chiba H; Matsunaga T; Kuroda H; Kusakabe T; Akiyama T; Kato J; Niitsu Y Am J Hematol; 2003 Aug; 73(4):285-9. PubMed ID: 12879435 [TBL] [Abstract][Full Text] [Related]
5. How can we help patients with refractory chronic graft versus host disease- single centre experience. Rzepecki P; Barzal J; Sarosiek T; Oborska S; Szczylik C Neoplasma; 2007; 54(5):431-6. PubMed ID: 17688373 [TBL] [Abstract][Full Text] [Related]
7. The effect of budesonide mouthwash on oral chronic graft versus host disease. Sari I; Altuntas F; Kocyigit I; Sisman Y; Eser B; Unal A; Fen T; Ferahbas A; Ozturk A; Unal A; Cetin M Am J Hematol; 2007 May; 82(5):349-56. PubMed ID: 17109390 [TBL] [Abstract][Full Text] [Related]
8. Effects of sarpogrelate hydrochloride on adenosine diphosphate- or collagen-induced platelet responses in arteriosclerosis obliterans. Nakamura K; Kariyazono H; Masuda H; Sakata R; Yamada K Blood Coagul Fibrinolysis; 2001 Jul; 12(5):391-7. PubMed ID: 11505083 [TBL] [Abstract][Full Text] [Related]
9. Risk-factor analysis for predicting progressive- or quiescent-type chronic graft-versus-host disease in a patient cohort with a history of acute graft-versus-host disease after allogeneic stem cell transplantation. Sohn SK; Kim DH; Baek JH; Kim JG; Lee KB; Lee KH; Lee JH; Choi SJ; Lee JH; Shin IH Bone Marrow Transplant; 2006 Apr; 37(7):699-708. PubMed ID: 16501588 [TBL] [Abstract][Full Text] [Related]
10. Increased donor CD86+CD14+ cells in the bone marrow and peripheral blood of patients with chronic graft-versus-host disease. Arpinati M; Chirumbolo G; Marzocchi G; Baccarani M; Rondelli D Transplantation; 2008 Jun; 85(12):1826-32. PubMed ID: 18580477 [TBL] [Abstract][Full Text] [Related]
11. Two cases of cutaneous chronic graft versus host disease in treatment with psoralen plus ultraviolet-A-bath photochemotherapy. Hoffner MV; Carrizosa Esquivel A; Pulpillo Ruiz A; Herrera Saval A; Conejo-Mir J; Camacho FM J Drugs Dermatol; 2009 Nov; 8(11):1027-9. PubMed ID: 19894371 [TBL] [Abstract][Full Text] [Related]
12. Chronic graft versus host disease of oral mucosa: review of available therapies. Imanguli MM; Pavletic SZ; Guadagnini JP; Brahim JS; Atkinson JC Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Feb; 101(2):175-83. PubMed ID: 16448918 [TBL] [Abstract][Full Text] [Related]
13. Effects of sarpogrelate hydrochloride on skin ulcers and quality of life in patients with systemic sclerosis. Yoshimasu T; Ikeda T; Uede K; Kanazawa N; Furukawa F J Dermatol; 2012 Jun; 39(6):536-40. PubMed ID: 22077618 [TBL] [Abstract][Full Text] [Related]
14. Pancreatic insufficiency in patients with chronic graft-versus-host disease. Akpek G; Valladares JL; Lee L; Margolis J; Vogelsang GB Bone Marrow Transplant; 2001 Jan; 27(2):163-6. PubMed ID: 11281385 [TBL] [Abstract][Full Text] [Related]
15. Oral involvement in chronic graft versus host disease: a prospective study of 19 Brazilian patients. Pereira CM; de Almeida OP; Correa ME; Souza CA; Barjas-Castro ML Gen Dent; 2007; 55(1):48-51. PubMed ID: 17333967 [TBL] [Abstract][Full Text] [Related]
16. Pemphigoid-like ocular lesions in patients with graft-versus-host disease following allogeneic bone marrow transplantation. Karwacka E; OĊdakowska-Jedynak U; Brydak-Godowska J; Paczek L; Kecik D Transplant Proc; 2006; 38(1):292-4. PubMed ID: 16504728 [TBL] [Abstract][Full Text] [Related]
17. Sclerodermatous chronic graft-versus-host disease--a report of four pediatric cases. Tolland JP; Devereux C; Jones FC; Bingham EA Pediatr Dermatol; 2008; 25(2):240-4. PubMed ID: 18429789 [TBL] [Abstract][Full Text] [Related]
18. Sarpogrelate hydrochloride, a selective 5-HT2A antagonist, improves vascular function in patients with peripheral arterial disease. Miyazaki M; Higashi Y; Goto C; Chayama K; Yoshizumi M; Sanada H; Orihashi K; Sueda T J Cardiovasc Pharmacol; 2007 Apr; 49(4):221-7. PubMed ID: 17438407 [TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease. Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422 [TBL] [Abstract][Full Text] [Related]
20. Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease. Lee S; Cho BS; Kim SY; Choi SM; Lee DG; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Shin WS; Kim CC Biol Blood Marrow Transplant; 2007 Sep; 13(9):1083-94. PubMed ID: 17697971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]